Cite
HARVARD Citation
Lawendy, N. et al. (n.d.). The effect of mild and moderate hepatic impairment on the pharmacokinetics of tofacitinib, an orally active Janus kinase inhibitor. Clinical pharmacology in drug development. 3 (6), pp. 421-427. [Online].